Katsiki N - Search Results

1

Lipid lowering nutraceuticals in clinical practice: position paper from an International Lipid Expert Panel.

Cicero AFG, Colletti A, Bajraktari G, Descamps O, Djuric DM, Ezhov M, Fras Z, Katsiki N, Langlois M, Latkovskis G, Panagiotakos DB, Paragh G, Mikhailidis DP, Mitchenko O, Paulweber B, Pella D, Pitsavos C, Reiner Ž, Ray KK, Rizzo M, Sahebkar A, Serban MC, Sperling LS, Toth PP, Vinereanu D, Vrablík M, Wong ND, Banach M. Cicero AFG, et al. Among authors: katsiki n. Arch Med Sci. 2017 Aug;13(5):965-1005. doi: 10.5114/aoms.2017.69326. Epub 2017 Aug 4. Arch Med Sci. 2017. PMID: 28883839 Free PMC article. No abstract available.

2

Sodium-lithium countertransport activity in healthy, dyslipidemic, and hypertensive individuals.

Savopoulos CG, Hatzitolios AI, Katsiki NA, Baltatzi M, Kosmidou M, Raikos N, Mikhailidis DP, Ziakas AG, Kaiafa G, Tsesmeli N. Savopoulos CG, et al. Among authors: katsiki na. Angiology. 2008 Dec-2009 Jan;59(6):727-35. doi: 10.1177/0003319708319784. Epub 2008 Oct 7. Angiology. 2008. PMID: 18840623

3

Ezetimibe in diabetes: more than cholesterol lowering?

Sarigianni M, Katsiki N, Mikhailidis DP. Sarigianni M, et al. Among authors: katsiki n. Curr Med Res Opin. 2010 Oct;26(10):2517-20. doi: 10.1185/03007995.2010.518519. Curr Med Res Opin. 2010. PMID: 20843163

4

Effects of combined ezetimibe and simvastatin therapy as compared with simvastatin alone in patients with type 2 diabetes: a prospective randomized double-blind clinical trial: comment on Ruggenenti et al.

Sarigianni M, Katsiki N, Mikhailidis DP. Sarigianni M, et al. Among authors: katsiki n. Diabetes Care. 2010 Oct;33(10):e132; author reply e133. doi: 10.2337/dc10-1250. Diabetes Care. 2010. PMID: 20876706 No abstract available.

5

Dapagliflozin: more than just another oral glucose-lowering agent?

Katsiki N, Papanas N, Mikhailidis DP. Katsiki N, et al. Expert Opin Investig Drugs. 2010 Dec;19(12):1581-9. doi: 10.1517/13543784.2011.539558. Expert Opin Investig Drugs. 2010. PMID: 21105857 Review.

6

New developments in the treatment and prevention of vascular disease--part 1.

Katsiki N, Athyros VG, Mikhailidis DP. Katsiki N, et al. Curr Pharm Des. 2010;16(34):3767-9. doi: 10.2174/138161210794455094. Curr Pharm Des. 2010. PMID: 21128889 No abstract available.

7

The DEFINE study: a bright future for CETP inhibitors?

Katsiki N, Athyros VG, Mikhailidis DP. Katsiki N, et al. Expert Opin Investig Drugs. 2011 Mar;20(3):311-4. doi: 10.1517/13543784.2011.550571. Epub 2011 Jan 17. Expert Opin Investig Drugs. 2011. PMID: 21235422 No abstract available.

8

Naltrexone sustained-release (SR) + bupropion SR combination therapy for the treatment of obesity: 'a new kid on the block'?

Katsiki N, Hatzitolios AI, Mikhailidis DP. Katsiki N, et al. Ann Med. 2011 Jun;43(4):249-58. doi: 10.3109/07853890.2010.541490. Epub 2011 Jan 24. Ann Med. 2011. PMID: 21254901 Free article. Review.

9

Effect of various treatments on leptin, adiponectin, ghrelin and neuropeptide Y in patients with type 2 diabetes mellitus.

Katsiki N, Mikhailidis DP, Gotzamani-Psarrakou A, Yovos JG, Karamitsos D. Katsiki N, et al. Expert Opin Ther Targets. 2011 Apr;15(4):401-20. doi: 10.1517/14728222.2011.553609. Epub 2011 Jan 25. Expert Opin Ther Targets. 2011. PMID: 21261565 Review.

10

Ezetimibe and low density lipoprotein subfractions: an ongoing debate.

Katsiki N, Athyros VG, Karagiannis A, Mikhailidis DP. Katsiki N, et al. Curr Med Res Opin. 2011 Mar;27(3):693-5. doi: 10.1185/03007995.2011.554809. Epub 2011 Jan 31. Curr Med Res Opin. 2011. PMID: 21275848

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

439 results

Search Page

Filters